Marshall Urist

RPRX

Marshall Urist serves as EVP, Research & Investments at Royalty Pharma plc (RPRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$9.61M

Net Position

Net Seller

$9.61M

Companies Traded

RPRX

Active Period

Dec 2025 – Jan 2026

10 total trades

Most Recent

Sell RPRX

Jan 30, 2026 · $821.8K

Marshall Urist's Insider Trading at Royalty Pharma plc (RPRX)

Buys

0 · $0.00

Sells

10 · $9.61M

Total Shares Bought

Total Shares Sold

243,151

RPRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 30, 2026↗	Sell	20,000	$41.09	$821.8K
Jan 23, 2026↗	Sell	20,000	$40.26	$805.1K
Jan 16, 2026↗	Sell	20,000	$39.52	$790.3K
Jan 9, 2026↗	Sell	20,000	$40.78	$815.6K
Jan 2, 2026↗	Sell	20,000	$38.48	$769.6K
Dec 26, 2025↗	Sell	20,000	$39.32	$786.4K
Dec 19, 2025↗	Sell	20,000	$38.38	$767.6K
Dec 16, 2025↗	Sell	20,000	$38.32	$766.4K
Dec 5, 2025↗	Sell	41,576	$39.15	$1.63M
Dec 1, 2025↗	Sell	41,575	$39.92	$1.66M

Related Insiders

Terrance P. Coyne

EVP & CFO

RPRXSell · Feb 4, 2026

George W. Lloyd

EVP, Investments & CLO

RPRXSell · Dec 18, 2025

Gregory Norden

Director

RPRXSell · Aug 11, 2025

Explore More Insider Trading Data

RPRX Insider Trading Activity

View all insider trades at Royalty Pharma plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity